Tarchomińskie Zakłady Farmaceutyczne Polfa S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-07-19
Share capital
184,913,610.00 PLN
Activity description

Tarchomińskie Zakłady Farmaceutyczne Polfa is a Polish pharmaceutical manufacturer that produces antibiotics, human insulin, dermatological medications, and dietary supplements. The company specializes in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms, operating under cGMP standards. They also provide laboratory services, conducting over 4,000 tests annually, and supply around 25 million packages of prescription and over-the-counter products to medical facilities each year.

Registered address
A. Fleminga 2, 03-176 Warszawa, Poland
Opening hours
Mon–Fri, 8:00–16:00
Email
Electronic delivery address
AE:PL-25871-63111-EGVCV-25

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$0

Filing timeliness

Financial statements were filed on time, on average 37 days early. All were audited by a statutory auditor.

  • 202517/06/2026
  • 202401/07/2025
  • 202302/07/2024
  • 202218/05/2023
  • 202106/07/2022
  • 202005/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Sanctions and PEP lists

PersonList
Witold PahlPoseł na Sejm RP
Witold PahlPoseł na Sejm Rzeczypospolitej Polskiej
Anna KąckaCzłonek organu spółki Skarbu Państwa
Mirosława DawidziukCzłonek organu spółki Skarbu Państwa

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 8.1%
Sector · Manufacturing728 / 24,548
Top 3.0%
City · Warszawa637 / 56,729
Top 1.1%
Voivodeship · Mazowieckie812 / 76,892
Top 1.1%
Country · Poland2,238 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 102.99mMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD 654.45kMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 96.17mMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 258.43mMedianUSD 897.46kAverageUSD 31.52m

Offer

Websites

  • tzfpolfa.plStrona główna – TZF Polfa
    WordPressYoast SEOWPMLNginx

Public procurement

The company is the contractor in one public sector contract, worth USD 486.22k.

SubjectAmount
Fee for renting an office building at ul. Fleminga for the needs of UD Białołęka m.st Warszawy
$486,224

Trademarks

The company holds 122 active trademarks registered with the Polish Patent Office. 3 applications are pending. 92 marks have expired or were not registered. The first mark was filed in 1966.

MarkNumberClassesStatusProtected until
DOPSYTAR (word)Z.5953145Protected Dec 15, 2035
POLF - FLU f Z.5922555Protected Oct 15, 2035
AZONID (word)Z.5890905Protected Aug 19, 2035
VELONOX (word)Z.5875015Protected Jul 15, 2035
BAXIREN (word)Z.5874985Protected Jul 15, 2035
MarkProtected until
DOPSYTAR (word)Dec 15, 2035
POLF - FLU f Oct 15, 2035
AZONID (word)Aug 19, 2035
VELONOX (word)Jul 15, 2035
BAXIREN (word)Jul 15, 2035

Job offers

The company has its own careers page: tzfpolfa.pl/kariera/oferty-pracy.

Authorized Representatives

Agnieszka Granas-Dominiak age 47 – Attorney-in-fact (joint)
Katarzyna Anna Piotrowska-Radziewicz age 43 – Członkini Zarządu
Bartosz Maciej Szałek age 54 – Attorney-in-fact (joint)
Wojciech Cezary Śniechowski age 51 – Attorney-in-fact (joint)
Marlena Dryżałowska age 40 – Attorney-in-fact (joint)

Manner of representation

Joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company. If the management board is a one-person management board, one member of the management board is authorised to make declarations of will on behalf of the company.

Supervisory board

Małgorzata Ewa Olszewska age 51 – Supervisory Board Member
Tomasz Gregorczyk age 51 – Supervisory Board Member
Leszek Marian Kalinowski age 64 – Supervisory Board Member
Marta Maciążek age 58 – Supervisory Board Member
Witold Pahl age 65 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1994-08-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$12.1M
Buildings and premises
$25.6M
Investment property
$22,602

MSiG notices

71 notices recorded in the Court and Commercial Gazette (MSiG).

Publication dateEvent
Nov 3, 2026Shareholders' meeting convened
May 26, 2026Shareholders' meeting convened
May 6, 2026Shareholders' meeting convened
Dec 3, 2025Shareholders' meeting convened
Nov 18, 2025Shareholders' meeting convened

Public aid

26 public aid cases recorded, with a total value of $4,944,672.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$37,817
De minimis aid (in accordance with Commission Regulation 2023/2831)
$62,602
De minimis aid (in accordance with Commission Regulation 2023/2831)
$3,014

Regulatory authorisations

AuthorityTypeStatus
Integrated permit Active

Competitors

Name
Biofarm sp. z o.o.
Zentiva Polska sp. z o.o.
Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A.
Przedsiębiorstwo Farmaceutyczne Lek-Am sp. z o.o.
Farmak International sp. z o.o.
MSD Polska sp. z o.o.
Synoptis Pharma sp. z o.o.
Polfarmex S.A.
Zakłady Farmaceutyczne Colfarm S.A.
Reig Jofre sp. z o.o.

Change history

DateEvent
2020-02-13Share capital increase
2001-07-19Entered in the register

FAQ

Last updated: 2026-08-03